Global Gastrointestinal agents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4313223
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc.
  • Janssen Biotech, Inc.
  • MORE
Gastrointestinal agents Market - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025, the global gastrointestinal agents market was valued at US$ 17,255.3 Mn in 2016, and is expected to reach US$ 21,177.7 Mn by 2025, expanding at a CAGR of 2.6% from 2017 to 2025.

Market Insights
Medications for gastrointestinal diseases and symptoms include prescription and nonprescription drugs, conventional and unconventional agents, simple small molecules, complex macromolecules and large recombinant proteins. These medications can be classified based upon their use: drugs for nausea and vomiting (antiemetics), prokinetic agents, laxatives, antidiarrheal agents, drugs for acid peptic disease, drugs for irritable bowel syndrome, inflammatory bowel disease and, of course, miscellaneous. Gastrointestinal disorders include conditions such as constipation, irritable bowel syndrome, hemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer. Many of these can be prevented or minimized by maintaining a healthy lifestyle, practicing good bowel habits, and submitting to cancer screening.

The global gastrointestinal agents market is segmented by drug type as antidiarrheal, anti-ulcers, laxatives, inflammatory bowel disease drugs and irritable bowel syndrome drugs. Among these, inflammatory bowel disease held the largest share in the gastrointestinal agents market due high prevalence of inflammatory bowel disease in the region.

As of the current market scenario, North America dominates the gastrointestinal agents market. The U.S., in particular captures the largest market share in the Americas gastrointestinal agents market. However, the region is expected to witness flat growth due to maturity of this market and no anticipated competition from potential drug. Asia Pacific is anticipated to be fastest growing market for the forecast period 2017-2015

Market Competition Assessment:

Key Players in the global gastrointestinal agents market are
Abbott Laboratories, Allergan Plc. (Formerly Actavis Plc.), AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Janssen Biotech, Inc, Ranbaxy Laboratories Limited, Sanofi, Takeda Pharmaceutical, Valeant Pharmaceuticals, Inc. and others

Key Market Movements:
  • Chronic digestive disorders such as irritable bowel syndrome, inflammatory bowel disease have being commonly observed recently. Gastrointestinal (GI) diseases account for substantial morbidity, mortality, and cost. Thus rising incidence of gastrointestinal disease is key driver for market growth
  • Enormous research and development is taking place in gastrointestinal therapy in pharma industry where it has seventh largest pipeline products, surpassing other therapy areas such as dermatology, ophthalmology and respiratory. There are many drugs and biologics in pipeline especially in phase 2 and phase 3 clinical trails
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc.
  • Janssen Biotech, Inc.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 Usp and Key Offerings
1.2 Research Methodology
1.2.1 Phase I - Secondary Research
1.2.2 Phase II - Primary Research
1.2.3 Phase III - Expert Panel Review
1.2.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Gastrointestinal Agents Market Portraiture
2.2 Global Gastrointestinal Agents Market Revenue, by Class, 2016 Vs 2025 (Value %)
2.3 Global Gastrointestinal Agents Market Revenue, by Geography, 2016 (US$ Million)

Chapter 3 Global Gastrointestinal Agents Market Analysis
3.1 Global Gastrointestinal Agents Market Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Rise in the Instances of Gastrointestinal Diseases and Disorders
3.2.1.2 Active Development in Pipelines Drugs and Biologics
3.2.2 Challenges
3.2.2.1 Most of the Patient Prefers Home Remedies in Its Initial Stage of Diseases
3.2.3 Opportunities
3.2.3.1 Rise in Used of Otc Drugs and Food Supplements
3.3 Food Supplements as Supportive Therapy for Gastrointestinal Diseases (2015-2016) (US$)
3.4 Incidence Rate of Gerd, Ibd and Ibs, 2016
3.5 Attractive Investment Proposition
3.6 Competitive Analysis: Key Players in Global Gastrointestinal Agents Market

Chapter 4 Gastrointestinal Agents Market Analysis, by Drug Class, 2015-2025 (US$ Mn)
4.1 Overview
4.2 Antidiarrheal
4.3 Anti-Emetics
4.3.1 Anticholinergic Agents
4.3.2 Antihistamines
4.3.3 Serotonin 5-Ht3 Receptor Antagonists
4.3.4 Cannabinoid Receptor Agonists
4.4 Anti-Ulcers
4.4.1 Histamine Type 2 Receptor Blockers (H2 Blockers)
4.4.2 Proton Pump Inhibitors
4.5 Laxatives
4.6 Inflammatory Bowel Disease
4.6.1 5-Aminosalicyclic Acid (5-Asa) Derivatives
4.6.2 Immunosuppressive Agents
4.6.3 Tumor Necrosis Factor Antagonists
4.7 Irritable Bowel Syndrome
4.7.1 Antimuscarinics/Antispasmodics
4.7.2 Prokinetic Agents

Chapter 5 Americal Gastrointestinal Agents Market, by Geography, 2015-2025 (US$ Mn)
5.1 Overview
5.2 North Americ (USa and Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, and Rest of Asia Pacific)
5.5 Latin America (Brazil, Mexico and Rest of Latin America)
5.6 Middle East and Africa (Uae, Saudi Arabia, South Africa and Rest of Middle East and Africa)

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Allergan Plc. (Formerly Actavis Plc.)
6.3 Astrazeneca
6.4 Bayer Ag
6.5 Boehringer Ingelheim Gmbh
6.6 Glaxosmithkline Plc
6.7 Janssen Biotech, Inc
6.8 Ranbaxy Laboratories Limited
6.9 Sanofi
6.10 Takeda Pharmaceutical
6.11 Valeant Pharmaceuticals, Inc

List of Figures
Figure 1 Global Gastrointestinal Agents Market: Research Methodology
Figure 2 Global Gastrointestinal Agents Market Revenue, by Class, 2016 Vs 2025 (Value %)
Figure 3 Global Gastrointestinal Agents Market Revenue, by Geography, 2016 (US$ Million)
Figure 4 Attractive Investment Proposition: Global Gastrointestinal Agents Market
Figure 5 Competitive Analysis: Key Players in Global Gastrointestinal Agents Market
Figure 6 Antidiarrheal Market, 2015 - 2025 (US$ Mn)
Figure 7 Anticholinergic Agents Market, 2015 - 2025 (US$ Mn)
Figure 8 Antihistamine Agents Market, 2015 - 2025 (US$ Mn)
Figure 9 Serotonin 5-Ht3 Receptor Antagonists Market, 2015 - 2025 (US$ Mn)
Figure 10 Cannabinoid Receptor Agonists Market, 2015 - 2025 (US$ Mn)
Figure 11 Histamine Type 2 Receptor Blockers (H2 Blockers) Market, 2015 - 2025 (US$ Mn)
Figure 12 Proton Pump Inhibitors Market, 2015 - 2025 (US$ Mn)
Figure 13 Laxatives Market, 2015 - 2025 (US$ Mn)
Figure 14 5-Aminosalicylic Acid Derivatives Market, 2015 - 2025 (US$ Mn)
Figure 15 Immunosuppressive Agents Market, 2015 - 2025 (US$ Mn)
Figure 16 Tumor Necrosis Factor Antagonists Market, 2015 - 2025 (US$ Mn)
Figure 17 Antimuscarinics/Antispasmodics Market, 2015 - 2025 (US$ Mn)
Figure 18 Prokinetic Agents Market, 2015 - 2025 (US$ Mn)
Figure 19 Latin America Gastrointestinal Agents, 2013 - 2024 (US$ Mn)
Figure 20 Middle East & Africa Gastrointestinal Agents, 2013 - 2024 (US$ Mn)

List of Tables
Table 1 Food Supplements as Supportive Therapy for Gastrointestinal Diseases (2015-2016) (US$)
Table 2 Incidence Rate of Gerd, Ibd and Ibs, 2016
Table 3 Global Gastrointestinal Agents Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 4 Anti-Emetics Global Gastrointestinal Agents Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 5 Anti-Ulcers Global Gastrointestinal Agents Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 6 Global Inflammatory Bowel Disease Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 7 Global Irritable Bowel Disease Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 8 Global Gastrointestinal Agents Market, by Region, 2015 - 2025 (US$ Mn)
Table 9 North America Gastrointestinal Agents Market, by Region, 2015 - 2025 (US$ Mn)
Table 10 Europe Gastrointestinal Agents, by Country, 2015 - 2025 (US$ Mn)
Table 11 Asia Pacific Gastrointestinal Agents, by Country, 2013 - 2024 (US$ Mn)
Table 12 Abbott Laboratories: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 13 Allergan Plc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 14 Astrazeneca: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 15 Bayer Ag: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 16 Boehringer Ingelheim Gmbh: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 17 Glaxosmithkline Plc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 18 Janssen Biotech, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 19 Ranbaxy Laboratories Limited: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 20 Sanofi: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 21 Takeda Pharmaceutical: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 22 Valeant Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Allergan Plc. (Formerly Actavis Plc.)
  • AstraZeneca
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc.
  • Janssen Biotech, Inc.
  • Ranbaxy Laboratories Limited
  • Sanofi
  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll